Vultaggio Vincent
PAO and PFO
Vultaggio Vincent has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Feb 10, 2026.
On the most recent filing, Vultaggio Vincent is listed as PAO and PFO at Zentalis Pharmaceuticals, Inc. Inside the rolling window, Vultaggio Vincent reported no open-market purchases and 5 open-market sales totaling $105K in ZNTL. The largest disclosed transaction in the window is a sale of 29,951 ZNTL shares on Feb 6, 2026, worth $73K.
Companies traded
Other insiders at ZNTL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$105K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Vultaggio Vincent made?
Vultaggio Vincent has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Vultaggio Vincent trade?
Vultaggio Vincent has filed SEC Form 4 disclosures for 1 company, including ZNTL.
When was Vultaggio Vincent's most recent SEC Form 4 filing?
Vultaggio Vincent's most recent SEC Form 4 filing on Tracefour is dated Feb 10, 2026.
What is Vultaggio Vincent's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Vultaggio Vincent is listed as PAO and PFO.
What is Vultaggio Vincent's total buy and sell value in the current window?
Inside the rolling retention window, Vultaggio Vincent bought $0 and sold $105K based on SEC Form 4 filings.
What was Vultaggio Vincent's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 29,951 ZNTL shares on 2026-02-06, worth $73K, per SEC Form 4 filings.